Invasive lobular carcinoma of the male breast

Canadian Journal of Surgery

Volumn 49, Issue 5, 2006, Pages 365-366

  Erhan, Yamaç ^a,c   Zekioglu, Osman ^b   Erhan, Yildiz ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; KI 67 ANTIGEN; PROTEIN P53; TAMOXIFEN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BREAST EXAMINATION; CASE REPORT; HISTOLOGY; HUMAN; INVASIVE LOBULAR CARCINOMA; LYMPH NODE DISSECTION; MALE; MAMMOGRAPHY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; TUMOR ASSOCIATED LEUKOCYTE;

BREAST NEOPLASMS, MALE; CARCINOMA, LOBULAR; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 33845307547     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Donegan WL, Redlich PN, Lang PJ, et al. Carcinoma of the breast in males: a multiinstitutional survey. Cancer 1998;83:498-509.
2. Salvadori B, Saccozzi R, Manzari A, et al. Prognosis of breast cancer in males: an analysis of 170 cases. Eur J Cancer 1994;30A:930-5.
3. Surveillance, Epidemiology, and End Results (SEER) Program. Public-use data. (1993-1997). Bethesda (MD): National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2000.
4. Donegan WL. Cancer of the male breast. In: Donegan WL, Spratt JS, editors. Cancer of the breast. Philadelphia: WB Saunders Company; 1995. p. 765-77.
5. Goss PE, Reid C, Pintilie M, et al. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 1999;85:629-39.
6. Cutuli B, Lacroze M, Dilhuydy JM, et al. Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer 1995;31A:1960-4.